Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2025-12-29 @ 9:04 PM
Study NCT ID:
NCT01381692
Status:
COMPLETED
Last Update Posted:
2021-10-04
First Post:
2011-06-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2014-12-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-23
First Submit QC Date:
None
Study First Post Date:
2011-06-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-04-09
Results First Submit QC Date:
None
Results First Post Date:
2021-05-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-04
Last Update Post Date:
2021-10-04
Last Update Post Date Type:
ACTUAL